Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecasts to 2024
The global multimodal imaging market size is projected to reach USD 2.9 billion by 2024, at a CAGR of 4.4%. Growing applications of multimodal imaging systems, technological advancements in diagnostic imaging modalities, availability of funding for research, favorable reimbursement scenario, growing insurance coverage, and increasing R&D into radiotracers are some of the key factors driving the market.
By technology, the PET/CT systems segment is expected to grow at the highest rate during the forecast period
Based on technology, the multimodal imaging market is broadly segmented into PET/CT systems, PET/MR systems, SPECT/CT systems, OCT/Fundus Imaging systems, and other multimodal imaging systems (tri-modality systems such as SPECT/CT/PET, PET/CT + MR, and IVUS + NIRS systems, among others). The PET/CT systems segment accounted for the largest share of the market in 2018. This can be attributed to the increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimers disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenario, and the technological advancements in the field of PET/CT.
By application, the oncology segment was the largest contributor to the multimodal imaging market in 2018
On the basis of application, the market is segmented into brain & neurology, cardiology, oncology, ophthalmology, and other applications. The oncology segment accounted for the largest market share in 2018. This can be attributed to the expanding use of multimodal imaging systems in oncology diagnosis, increasing demand for the early & accurate diagnosis of cancer, and growing clinical evidence on the use of multimodal imaging in the diagnosis of novel cancer types.
The hospitals' segment was the largest contributor to the multimodal imaging market, by end user, in 2018
Based on end user, the multimodal imaging market is segmented into hospitals, diagnostic imaging centers, and other end users. The hospitals segment accounted for the largest market share in 2018. The growing number of installations of technologically advanced multimodal imaging systems like PET/CT and SPECT/CT systems in hospitals, growing demand for non-invasive diagnostic procedures, and widening applications of multimodal imaging systems, especially to perform early and accurate diagnosis of various diseases are some of the major factors driving the growth of the hospitals segment.
Asia Pacific is expected to grow at the highest CAGR during the forecast period
Asia Pacific is expected to grow at the highest CAGR during the forecast period. Emerging economies in the region such as India, China, and South Korea, along with developed markets such as Japan and Australia, are offering high-growth opportunities for market players in the field of multimodal imaging. This can be attributed to factors such as the improving healthcare infrastructure, increasing investments in multimodal imaging, and the improving reimbursement scenario.
Key Market Players
The major players operating in the multimodal imaging market include GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Canon, Inc. (Japan), United Imaging Healthcare Co., Ltd. (China), Mediso Medical Imaging Systems Kft (Hungary), Neusoft Medical Systems Co., Ltd. (China), Infraredx, Inc. (a part of Nipro Corporation) (Japan), Spectrum Dynamics Medical (Switzerland), Topcon Corporation (Japan), Heidelberg Engineering (Germany), Carl Zeiss AG (Germany), Optovue, Inc. (US), Nidek Co., Ltd (Japan), Optos Plc (UK) (a part of Nikon Corporation), and Kowa Company, Ltd. (Japan), among others.
An analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches & enhancements, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the market. Among these business strategies, partnerships and agreements were the most widely adopted growth strategies by market players.
GE Healthcare (US), dominated the market in 2018. The company offers a broad range of products integral to the market, which are widely used in key regions such as North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. GE Healthcare mainly focuses on the development of innovative products to further strengthen its position in the multimodal imaging market. Some key offerings of the company include SPECT/CT systems such as Discovery NM/CT 570c, PET/CT systems such as Discovery MI, SIGNA PET/MR system, and PET/CT + MR Trimodality Imaging, among other products.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
20172024 |
|
Base year considered |
2018 |
|
Forecast period |
20192024 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Technology, Application, End user, and Region |
|
Geographies covered |
North America (US and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia Pacific (China, Japan, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa |
|
Companies covered |
Major twelve players covered, include GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd. (China), Canon Medical Systems Corporation (Japan), Mediso Medical Imaging Kft (Hungary), Neusoft Medical Systems Co., Ltd. (China), Spectrum Dynamics Medical (Switzerland), Infraredx, Inc. (Japan), Topcon Corporation (Japan), Carl Zeiss AG (Germany), and Heidelberg Engineering (Germany). |
This research report categorizes the market into the following segments and subsegments:
Multimodal imaging Market, by Technology
- PET/CT Systems
- SPECT/CT Systems
- PET/MR Systems
- OCT/Fundus Imaging Systems
- Other Multimodal Imaging Systems
Multimodal imaging Market, by Application
- Brain & Neurology
- Cardiology
- Oncology
- Ophthalmology
- Other Applications
Multimodal imaging Market, by End User
- Hospitals
- Diagnostic Imaging Centers
- Other End Users
Multimodal imaging Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- RoE
- Asia Pacific
- China
- Japan
- India
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLATAM
- The Middle East and Africa
Note
1: Other multimodal imaging systems include trimodal systems, including PET/CT + MR systems, SPECT+PET+CT systems, and intravascular ultrasound (IVUS) + near-infrared spectroscopy (NIRS) systems.
2: Other applications include conditions that occur in the musculoskeletal system, such as orthopedics, metabolic disorders, disorders occurring in lymph and blood vessels, inflammation, infection, and renal disorders.
3: Other end users include academic and research institutions, government institutions, pharmaceutical & biotechnology companies, eye hospitals & diagnostic eye care centers, sports studios, mobile radiology service providers, and CROs.
Recent Developments:
- In 2019, United Imaging Healthcare Co., Ltd. (China) launched its uEXPLORER (full body PET/CT).
- In 2018, GE Healthcare (US) launched its 800 series SPECT/CT systems that include NM/CT 850, NM/CT 860, NM/CT 870 DR, and NM/CT 870 CZT.
- In 2017, Siemens Healthineers (Germany) Launched its Biograph Vision PET/CT system.
- In 2016, Canon Inc. (Japan) completed the acquisition of Toshiba Medical Systems Corporation, with the aim to include its diagnostic imaging portfolio in its offering and expand its healthcare business, globally.
Key Questions Addressed by the Report:
- What are the growth opportunities related to the adoption of multimodal imaging across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of multimodal imaging procedures. Will this scenario continue in the next five years?
- Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
Frequently Asked Questions (FAQ):
What is the expected addressable market value of major multimodal imaging products over a 5-year period?
Based on the prevailing trends and estimated market value data as of 2019, the total market value of major multimodal imaging products is estimated to be about USD 2.9 billion as of 2024.
Which technology segments are expected to garner highest traction within multimodal imaging market?
PET/CT and SPECT/CT are expected to be the fastest growing technology segments within this industry during 2019-2024 period. Revenue growth witnessed by these segments is mainly due to rising prevalence of major cancers, greater utilization among hospitals in major markets, and significant adoption of multimodal systems (as compared to standalone PET or SPECT) worldwide.
What are the opportunistic areas are available for new and existing players in the multimodal imaging market to enhance their market share?
Expansion of application horizons of multimodal diagnostic platforms, their greater utilization in researches, and increased availability of government reimbursements are some of the key opportunistic areas available for the emerging as well as established players in the market.
What are the major revenue pockets in the multimodal imaging market currently?
The highest market share of multimodal imaging is estimated to belong to the North America with ~35% share as of 2019; closely followed by Europe. Significant market share of North America in the overall industry is mainly due to rapid replacement of standalone systems among hospitals, increased utilization of target products in oncology & neurology, and supportive government regulations in the US.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 18)
2.1 Secondary and Primary Research Methodology
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions and Limitations
2.4.1 Assumptions for the Study
2.4.2 Limitations
3 Executive Summary (Page No. - 29)
4 Premium Insights (Page No. - 33)
4.1 Multimodal Imaging: Market Overview
4.2 Geographic Analysis: Multimodal Imaging Market Share, By Application and Region, 2018
4.3 Technology Analysis: Market Size, 2019 vs 2024 (USD Million)
4.4 End-User Analysis: Market Share, 2019 vs 2024
4.5 Geographic Snapshot of the Market
5 Market Overview (Page No. - 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Applications of Multimodal Imaging Systems
5.2.1.2 Technological Advancements in Diagnostic Imaging Modalities
5.2.1.3 Availability of Funding for Research
5.2.2 Restraints
5.2.2.1 High Cost of Multimodal Imaging Systems
5.2.2.2 Lack of Adequate Healthcare Infrastructure
5.2.3 Opportunities
5.2.3.1 Availability of Reimbursement and Insurance Coverage for Scans
5.2.3.2 Increasing R&D Into Radiotracers
5.2.4 Challenges
5.2.4.1 Dearth of Trained Professionals
6 Multimodal Imaging Market, By Technology (Page No. - 44)
6.1 Introduction
6.2 PET/CT Systems
6.2.1 PET/CT Systems Have Almost Practically Replaced Stand-Alone PET Systems Across the World
6.2.2 PET/CT Systems Market Split By Application, 20172024 (USD Million)
6.2.3 PET/CT Systems Market Split By End User, 20172024 (USD Million)
6.3 SPECT/CT Systems
6.3.1 Improved Resolution of SPECT/CT Systems has Provided A Clear Advantage Over Stand-Alone Spect Systems
6.3.2 SPECT/CT Systems Market Split By Application, 20172024 (USD Million)
6.3.3 SPECT/CT Systems Market Split By End User, 20172024 (USD Million)
6.4 PET/MR Systems
6.4.1 PET/MR Systems Showcase Increasing Clinical Evidence With Enhanced Tissue Contrast
6.4.2 PET/MR Systems Market Split By Application, 20172024 (USD Million)
6.4.3 PET/MR Systems Market Split By End User, 20172024 (USD Million)
6.5 OCT/Fundus Imaging Systems
6.5.1 OCT/Fundus Imaging Systems Have Wide Applications in Retinal Disease Diagnosis
6.5.2 OCT/Fundus Imaging Systems Market Split By Application, 20172024 (USD Million)
6.5.3 OCT/Fundus Imaging Systems Market Split By End User, 20172024 (USD Million)
6.6 Other Multimodal Imaging Systems
6.6.1 Other Multimodal Imaging Systems Market Split By Application, 20172024 (USD Million)
6.6.2 Other Multimodal Imaging Systems Market Split By End User, 20172024 (USD Million)
7 Multimodal Imaging Market, By Application (Page No. - 57)
7.1 Introduction
7.2 Oncology
7.2.1 Oncology is the Largest Application Segment of the Market
7.3 Ophthalmology
7.3.1 Technological Innovations in Ophthalmic Multimodal Imaging Systems By Key Market Players to Support Market Growth
7.4 Cardiology
7.4.1 Increasing Prevalence of Cardiac Conditions & Increasing Demand for Early Disease Diagnosis to Support Market Growth
7.5 Brain & Neurology
7.5.1 Increasing Incidence of Brain & Neurological Disorders to Propel the Adoption of Multimodal Imaging Systems
7.6 Other Applications
8 Multimodal Imaging Market, By End User (Page No. - 65)
8.1 Introduction
8.2 Hospitals
8.2.1 Large Hospitals With Nuclear Medicine Departments Have Been Early Adopters of Multimodal Imaging Systems
8.3 Diagnostic Imaging Centers
8.3.1 Increasing Number of Private Imaging Centers is Contributing to the Growth of This Segment
8.4 Other End Users
9 Multimodal Imaging Market, By Region (Page No. - 72)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Market
9.2.2 Canada
9.2.2.1 Government Budget Cuts and Long Wait Time for Scans to Hamper the Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Favorable Reimbursement Scenario in the Country to Support Market Growth
9.3.2 UK
9.3.2.1 Government Initiatives and the Increasing Number of Funding and Research Activities Related to the Use of Multimodal Imaging are Driving Market Growth
9.3.3 France
9.3.3.1 France has the Third-Largest Government Expenditure on HealthcareA Major Factor Driving Market Growth
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Large Installation Base of Hybrid Imaging Systems A Major Factor Driving Market Growth
9.4.2 China
9.4.2.1 China to Witness the Highest Growth Rate in the Global Market During the Forecast Period
9.4.3 India
9.4.3.1 Lack of Reimbursement for Diagnostic Imaging Procedures to Hamper Market Growth
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Brazil Dominates the Latin American Market Due to the High Burden of Cancer
9.5.2 Mexico
9.5.2.1 Rising Incidence of Cancer to Drive Market Growth in Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Improved Healthcare Infrastructure and Growing Awareness of Multimodal Imaging are Driving Market Growth in the Mea
10 Competitive Landscape (Page No. - 101)
10.1 Introduction
10.2 Market Share Analysis, 2018
10.3 Competitive Situation and Trends
10.4 Competitive Leadership Mapping
10.5 Vendor Inclusion Criteria
10.6 Vendor Dive
10.6.1 Visionary Leaders
10.6.2 Innovators
10.6.3 Dynamic Differentiators
10.6.4 Emerging Players
11 Company Profiles (Page No. - 107)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Canon, Inc.
11.2 GE Healthcare
11.3 Heidelberg Engineering
11.4 Infraredx, Inc. (A Part of Nipro Corporation)
11.5 Koninklijke Philips N.V.
11.6 Mediso Medical Imaging Systems Kft
11.7 Neusoft Medical Systems Co., Ltd
11.8 Siemens Healthineers
11.9 Spectrum Dynamics Medical
11.10 Topcon Corporation
11.11 United Imaging Healthcare Co., Ltd.
11.12 Zeiss Group
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 131)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
List of Tables (69 Tables)
Table 1 Technological Advancements in Multimodal Imaging Systems (20172019)
Table 2 Codes for SPECT/CT Fusion Imaging (As of June 2019)
Table 3 National PET, PET/CT, PET/MRi Coverage for Oncology (As of June 2013)
Table 4 Market, By Technology, 20172024 (USD Million)
Table 5 PET/CT Systems Market, By Region, 20172024 (USD Million)
Table 6 PET/CT Systems Market, By Application, 20172024 (USD Million)
Table 7 PET/CT Systems Market, By End User, 20172024 (USD Million)
Table 8 SPECT/CT Systems Market, By Region, 20172024 (USD Million)
Table 9 SPECT/CT Systems Market, By Application, 20172024 (USD Million)
Table 10 SPECT/CT Systems Market, By End User, 20172024 (USD Million)
Table 11 PET/MR Systems Market, By Region, 20172024 (USD Million)
Table 12 PET/MR Systems Market, By Application, 20172024 (USD Million)
Table 13 PET/MR Systems Market, By End User, 20172024 (USD Million)
Table 14 OCT/Fundus Imaging Systems Market, By Region, 20172024 (USD Million)
Table 15 OCT/Fundus Imaging Systems Market, By Application, 20172024 (USD Million)
Table 16 OCT/Fundus Imaging Systems Market, By End User, 20172024 (USD Million)
Table 17 Other Multimodal Imaging Systems Market, By Region, 20172024 (USD Million)
Table 18 Other Multimodal Imaging Systems Market, By Application, 20172024 (USD Million)
Table 19 Other Multimodal Imaging Systems Market, By End User, 20172024 (USD Million)
Table 20 Multimodal Imaging Market, By Application, 20172024 (USD Million)
Table 21 Market for Oncology Applications, By Region, 20172024 (USD Million)
Table 22 Market for Ophthalmology Applications, By Region, 20172024 (USD Million)
Table 23 Market for Cardiology Applications, By Region, 20172024 (USD Million)
Table 24 Market for Brain and Neurology Applications, By Region, 20172024 (USD Million)
Table 25 Market for Other Applications, By Region, 20172024 (USD Million)
Table 26 Market, By End User, 20172024 (USD Million)
Table 27 Multimodal Imaging Systems Installed in Hospitals
Table 28 Market for Hospitals, By Region, 20172024 (USD Million)
Table 29 Multimodal Imaging Systems Installed in Diagnostic Imaging Centers
Table 30 Market for Diagnostic Imaging Centers, By Region, 20172024 (USD Million)
Table 31 Multimodal Imaging Systems Installed in Research and Academic Institutes
Table 32 Market for Other End Users, By Region, 20172024 (USD Million)
Table 33 Market, By Region, 20172024 (USD Million)
Table 34 North America: Multimodal Imaging Market, By Country, 20172024 (USD Million)
Table 35 North America: Market, By Technology, 20172024 (USD Million)
Table 36 North America: Market, By Application, 20172024 (USD Million)
Table 37 North America: Market, By End User, 20172024 (USD Million)
Table 38 US: Market, By Technology, 20172024 (USD Million)
Table 39 Canada: Market, By Technology, 20172024 (USD Million)
Table 40 Europe: Market, By Country, 20172024 (USD Million)
Table 41 Europe: Market, By Technology, 20172024 (USD Million)
Table 42 Europe: Market, By Application, 20172024 (USD Million)
Table 43 Europe: Market, By End User, 20172024 (USD Million)
Table 44 Germany: Market, By Technology, 20172024 (USD Million)
Table 45 UK: Market, By Technology, 20172024 (USD Million)
Table 46 France: Market, By Technology, 20172024 (USD Million)
Table 47 Rest of Europe: Market, By Technology, 20172024 (USD Million)
Table 48 Asia Pacific: Multimodal Imaging Market, By Country, 20172024 (USD Million)
Table 49 Asia Pacific: Market, By Technology, 20172024 (USD Million)
Table 50 Asia Pacific: Market, By Application, 20172024 (USD Million)
Table 51 Asia Pacific: Market, By End User, 20172024 (USD Million)
Table 52 Japan: Market, By Technology, 20172024 (USD Million)
Table 53 China: Market, By Technology, 20172024 (USD Million)
Table 54 India: Market, By Technology, 20172024 (USD Million)
Table 55 Rest of Asia Pacific: Market, By Technology, 20172024 (USD Million)
Table 56 Latin America: Market, By Country, 20172024 (USD Million)
Table 57 Latin America: Multimodal Imaging Market, By Technology, 20172024 (USD Million)
Table 58 Latin America: Market, By Application, 20172024 (USD Million)
Table 59 Latin America: Market, By End User, 20172024 (USD Million)
Table 60 Brazil: Market, By Technology, 20172024 (USD Million)
Table 61 Mexico: Market, By Technology, 20172024 (USD Million)
Table 62 Rest of Latin America: Market, By Technology, 20172024 (USD Million)
Table 63 Middle East & Africa: Multimodal Imaging Market, By Technology, 20172024 (USD Million)
Table 64 Middle East & Africa: Market, By Application, 20172024 (USD Million)
Table 65 Middle East & Africa: Market, By End User, 20172024 (USD Million)
Table 66 Product Launches, Approvals, and Enhancements
Table 67 Agreements, Partnerships, and Collaborations
Table 68 Expansions
Table 69 Acquisitions
List of Figures (30 Figures)
Figure 1 Multimodal Imaging Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Overall Market
Figure 6 Market: Data Triangulation Methodology
Figure 7 Market, By Technology, 2019 vs. 2024 (USD Million)
Figure 8 Market, By Application, 2019 vs. 2024 (USD Million)
Figure 9 Market Share, By End User, 2019 vs. 2024 (USD Million)
Figure 10 Geographical Snapshot of the Multimodal Imaging Market
Figure 11 Technological Advancements in Multimodal Imaging and Demand for Early Diagnosis are Driving Market Growth
Figure 12 Oncology Segment is Expected to Dominate the Market With the Largest Share of the Market
Figure 13 PET/CT Segment is Expected to Hold the Dominant Market Share During the Forecast Period
Figure 14 Hospitals Segment is Expected to Hold A Dominant Market Share During the Forecast Period
Figure 15 China to Register the Highest CAGR During the Forecast Period
Figure 16 Multimodal Imaging Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Key Developments in the Market Between 2016 and 2019
Figure 21 Global Imaging Market Share, By Key Player, 2018
Figure 22 Market (Global) Competitive Leadership Mapping, 2018
Figure 23 Canon, Inc.: Company Snapshot
Figure 24 GE Healthcare: Company Snapshot
Figure 25 Nipro Corporation: Company Snapshot
Figure 26 Koninklijke Philips N.V.: Company Snapshot
Figure 27 Neusoft: Company Snapshot
Figure 28 Siemens AG: Company Snapshot
Figure 29 Topcon Corporation: Company Snapshot
Figure 30 Carl Zeiss AG: Company Snapshot
The study involved four major activities to estimate the current market size for global multimodal imaging market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
The global multimodal imaging market comprises several stakeholders such as multimodal imaging systems manufacturers, multimodal imaging systems distributors & suppliers, cyclotron manufacturers and nuclear medicine based R&D companies.
The demand side of this market is characterized by significant use of multimodal imaging due to factors such as growing demand for early and accurate cancer diagnosis, rise in the cancer population, and favorable reimbursement scenario. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the multimodal imaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research.
- The industrys supply chain and market size, in terms of value, have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size-using the market size estimation processes as explained abovethe market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the multimodal imaging industry.
Report Objectives
- To define, describe, and forecast the multimodal imaging market by technology, application, end user, and region
- To provide detailed information about major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the revenue of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches; agreements, partnerships, and joint ventures; mergers & acquisitions; expansions; and research & development activities in the market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Product Analysis:
- Product matrix, which gives a detailed comparison of the product portfolios of major five companies
Company Information:
- Detailed analysis and profiling of additional market players (Up to 5)
Generating Response ...
Growth opportunities and latent adjacency in Multimodal Imaging Market